Vestal Point Capital »

Trevi Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 2.2M 11.93

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Trevi Therapeutics

NEA Management Company
BlackRock
Frazier Life Sciences Management
FMR
Vanguard Group
Vivo Capital
Vanguard Capital Management
Marshall Wace
Rubric Capital Management
Wellington Management Company
MPM Oncology Impact Management
Viking Global Investors
Alliancebernstein
Geode Capital Management
Eventide Asset Management

View all funds holding Trevi Therapeutics